Orphan Drug Designation and Exclusivity for “Same Drugs”

, &
Journal of Law, Medicine and Ethics 47 (2):347-349 (2019)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1177/1073110519857293

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,880

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Conflict of Interest Disclosure in Orphan Drug Research.Daniel Patrone, Jen-Ting Wang, Melissa Haig, Rosemary Harris, Rebecca LeFebvre, Matthew Vedete & Taylor Zelka - 2014 - Ethics in Biology, Engineering and Medicine 5 (3):259-269.
Disease awareness or subtle product placement? Orphan diseases featured in the television series “House, M.D.” - a cross-sectional analysis.Markus Ries, William K. Mountford, Juliane Rausch & Konstantin Mechler - 2020 - BMC Medical Ethics 21 (1):1-8.
State Driving Under the Influence of Drugs Laws.Alexandra N. Origenes, Sarah A. White, Emma E. McGinty & Jon S. Vernick - 2024 - Journal of Law, Medicine and Ethics 52 (S1):85-88.
Double bad luck: Should rare diseases get special treatment?Adam Hutchings - 2022 - Journal of Medical Ethics 48 (2):99-100.
Over-the-Counter Monograph Safety, Innovation, and Reform Act.Jason Gardiner & Aaron S. Kesselheim - 2021 - Journal of Law, Medicine and Ethics 49 (2):321-327.
Strategic Corporate Social Responsibility and Orphan Drug Development: Insights from the US and the EU Biopharmaceutical Industry. [REVIEW]Olga Bruyaka, Hanko K. Zeitzmann, Isabelle Chalamon, Richard E. Wokutch & Pooja Thakur - 2013 - Journal of Business Ethics 117 (1):45-65.
Extraordinary Pricing of Orphan Drugs: Is it a Socially Responsible Strategy for the U.S. Pharmaceutical Industry? [REVIEW]Thomas A. Hemphill - 2010 - Journal of Business Ethics 94 (2):225 - 242.
Promoting Competition in Drug Pricing: A Review of Recent Congressional Legislation. [REVIEW]Sarosh Nagar & Aaron S. Kesselheim - 2021 - Journal of Law, Medicine and Ethics 49 (4):683-687.
Ethical issues related to the access to orphan drugs in Brazil: the case of mucopolysaccharidosis type I.Raquel Boy, Ida V. D. Schwartz, Bárbara C. Krug, Luiz C. Santana-da-Silva, Carlos E. Steiner, Angelina X. Acosta, Erlane M. Ribeiro, Marcial F. Galera, Paulo G. C. Leivas & Marlene Braz - 2011 - Journal of Medical Ethics 37 (4):233-239.
Government Support of Meaningful Drug and Device Innovation: Pathways and Challenges.Aaron S. Kesselheim - 2023 - Journal of Law, Medicine and Ethics 51 (S2):7-15.

Analytics

Added to PP
2019-07-13

Downloads
28 (#810,662)

6 months
5 (#1,080,408)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references